Hainan Simcere Pharmaceutical Co Ltd
-
Simnotrelvir Tablets/Ritonavir Tablets received China special drug approval for COVID-19
Jan, 2023, Simnotrelvir Tablets/Ritonavir Tablets (co-packaged) submitted by Hainan Simcere Pharmaceutical Co., Ltd. received special drug approval as class 1 innovative drug for emergency application at China National Medical Products Administration (NMPA) with conditional requirements.